Cargando…
The Chemical and Pharmacological Properties of Mitragynine and Its Diastereomers: An Insight Review
Mitragynine, is a naturally occurring indole alkaloid that can be isolated from the leaves of a psychoactive medicinal plant. Mitragyna speciosa, also known as kratom, is found to possess promising analgesic effects on mediating the opioid receptors such as µ (MOR), δ (DOR), and κ (KOR). This alkalo...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8907881/ https://www.ncbi.nlm.nih.gov/pubmed/35281925 http://dx.doi.org/10.3389/fphar.2022.805986 |
_version_ | 1784665751720820736 |
---|---|
author | Karunakaran, Thiruventhan Ngew, Kok Zhuo Zailan, Ahmad Alif Danial Mian Jong, Vivien Yi Abu Bakar, Mohamad Hafizi |
author_facet | Karunakaran, Thiruventhan Ngew, Kok Zhuo Zailan, Ahmad Alif Danial Mian Jong, Vivien Yi Abu Bakar, Mohamad Hafizi |
author_sort | Karunakaran, Thiruventhan |
collection | PubMed |
description | Mitragynine, is a naturally occurring indole alkaloid that can be isolated from the leaves of a psychoactive medicinal plant. Mitragyna speciosa, also known as kratom, is found to possess promising analgesic effects on mediating the opioid receptors such as µ (MOR), δ (DOR), and κ (KOR). This alkaloid has therapeutic potential for pain management as it has limited adverse effect compared to a classical opioid, morphine. Mitragynine is frequently regarded to behave like an opioid but possesses milder withdrawal symptoms. The use of this alkaloid as the source of an analgesic candidate has been proven through comprehensive preclinical and clinical studies. The present data have shown that mitragynine is able to bind to opioid receptors, particularly MOR, to exhibit the analgesic effect. Moreover, the chemical and pharmacological aspects of mitragynine and its diastereomers, speciogynine, speciociliatine, and mitraciliatine, are discussed. It is interesting to know how the difference in stereochemical configuration could lead to the difference in the bioactivity of the respective compounds. Hence, in this review, the updated pharmacological and toxicological properties of mitragynine and its diastereomers are discussed to render a comprehensive understanding of the pharmacological properties of mitragynine and its diastereomers based on their structure–activity relationship study. |
format | Online Article Text |
id | pubmed-8907881 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-89078812022-03-11 The Chemical and Pharmacological Properties of Mitragynine and Its Diastereomers: An Insight Review Karunakaran, Thiruventhan Ngew, Kok Zhuo Zailan, Ahmad Alif Danial Mian Jong, Vivien Yi Abu Bakar, Mohamad Hafizi Front Pharmacol Pharmacology Mitragynine, is a naturally occurring indole alkaloid that can be isolated from the leaves of a psychoactive medicinal plant. Mitragyna speciosa, also known as kratom, is found to possess promising analgesic effects on mediating the opioid receptors such as µ (MOR), δ (DOR), and κ (KOR). This alkaloid has therapeutic potential for pain management as it has limited adverse effect compared to a classical opioid, morphine. Mitragynine is frequently regarded to behave like an opioid but possesses milder withdrawal symptoms. The use of this alkaloid as the source of an analgesic candidate has been proven through comprehensive preclinical and clinical studies. The present data have shown that mitragynine is able to bind to opioid receptors, particularly MOR, to exhibit the analgesic effect. Moreover, the chemical and pharmacological aspects of mitragynine and its diastereomers, speciogynine, speciociliatine, and mitraciliatine, are discussed. It is interesting to know how the difference in stereochemical configuration could lead to the difference in the bioactivity of the respective compounds. Hence, in this review, the updated pharmacological and toxicological properties of mitragynine and its diastereomers are discussed to render a comprehensive understanding of the pharmacological properties of mitragynine and its diastereomers based on their structure–activity relationship study. Frontiers Media S.A. 2022-02-24 /pmc/articles/PMC8907881/ /pubmed/35281925 http://dx.doi.org/10.3389/fphar.2022.805986 Text en Copyright © 2022 Karunakaran, Ngew, Zailan, Mian Jong and Abu Bakar. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Karunakaran, Thiruventhan Ngew, Kok Zhuo Zailan, Ahmad Alif Danial Mian Jong, Vivien Yi Abu Bakar, Mohamad Hafizi The Chemical and Pharmacological Properties of Mitragynine and Its Diastereomers: An Insight Review |
title | The Chemical and Pharmacological Properties of Mitragynine and Its Diastereomers: An Insight Review |
title_full | The Chemical and Pharmacological Properties of Mitragynine and Its Diastereomers: An Insight Review |
title_fullStr | The Chemical and Pharmacological Properties of Mitragynine and Its Diastereomers: An Insight Review |
title_full_unstemmed | The Chemical and Pharmacological Properties of Mitragynine and Its Diastereomers: An Insight Review |
title_short | The Chemical and Pharmacological Properties of Mitragynine and Its Diastereomers: An Insight Review |
title_sort | chemical and pharmacological properties of mitragynine and its diastereomers: an insight review |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8907881/ https://www.ncbi.nlm.nih.gov/pubmed/35281925 http://dx.doi.org/10.3389/fphar.2022.805986 |
work_keys_str_mv | AT karunakaranthiruventhan thechemicalandpharmacologicalpropertiesofmitragynineanditsdiastereomersaninsightreview AT ngewkokzhuo thechemicalandpharmacologicalpropertiesofmitragynineanditsdiastereomersaninsightreview AT zailanahmadalifdanial thechemicalandpharmacologicalpropertiesofmitragynineanditsdiastereomersaninsightreview AT mianjongvivienyi thechemicalandpharmacologicalpropertiesofmitragynineanditsdiastereomersaninsightreview AT abubakarmohamadhafizi thechemicalandpharmacologicalpropertiesofmitragynineanditsdiastereomersaninsightreview AT karunakaranthiruventhan chemicalandpharmacologicalpropertiesofmitragynineanditsdiastereomersaninsightreview AT ngewkokzhuo chemicalandpharmacologicalpropertiesofmitragynineanditsdiastereomersaninsightreview AT zailanahmadalifdanial chemicalandpharmacologicalpropertiesofmitragynineanditsdiastereomersaninsightreview AT mianjongvivienyi chemicalandpharmacologicalpropertiesofmitragynineanditsdiastereomersaninsightreview AT abubakarmohamadhafizi chemicalandpharmacologicalpropertiesofmitragynineanditsdiastereomersaninsightreview |